• Home
  • Beijing Minhai Biotechnology Co., Ltd

Beijing Minhai Biotechnology Co., Ltd

About Beijing Minhai Biotechnology Co., Ltd

A leading pharmaceutical company specializing in vaccine development and manufacturing.13-valent pneumococcal conjugate vaccine,
23-valent pneumococcal Polysaccharideconjugate vaccine,
Hepatisit B vaccine,
Varicella vaccine,
Rabies vaccine,
DTaP-Hib
Hib,
DTaP,
Penta valent vaccine,
IPV vaccine
TT vaccine
MMR vaccine,
4-valent influenza vaccine,



Read more Show less
Certifications
  • GMP
    GMP
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • CN
  • 2023
    On CPHI since
  • 1
    Certificates
  • 1000 - 4999
    Employees
Company types
Biopharmaceutical company
Primary activities
Biopharmaceutical
View company profile
Contact info
Show contact info Hide contact info
Meet us at

CPHI Frankfurt 2025

Messe, Frankfurt
28 Oct 2025 - 30 Oct 2025
View Exhibitor Profile

Products from Beijing Minhai Biotechnology Co., Ltd (3)

  • 13-valent pneumococcal conjugate vaccine

    Product 13-valent pneumococcal conjugate vaccine

    Protects against infectious diseases caused by pneumococcal types 1,3,4,5,6A,6B,7F,9V,14,18C,19A,19F and 23F, including pneumonia, meningitis, otitis media, bacteremia.

  • Recombinant Hepatitis B vaccine (Saccharomyces cerevisiae

    Product Recombinant Hepatitis B vaccine (Saccharomyces cerevisiae

    Recombinant Hepatitis B vaccine is a preparation made of purified hepatitis B surface antigen (HBsAg) expressed by the recombinant Saccharomyces cerevisiae. After purification of HBsAg, a quantity of aluminum adjuvant is added to make the vaccine. The vaccine is a milky-white suspension with stratified pre...
  • Varicella Vaccine, Live

    Product Varicella Vaccine, Live

    It can stimulate the body to produce immunity against varicella-zoster virus, which is used to prevent varicella.